46,160 ARS
340
0.74%
Last update Dec 16, 4:56 PM -03
Market closed
Day range
45,820
46,620
Previous close
45,820
Open
46,120
Access this stock data via API
Subscribe
Gilead Sciences Inc.
46,160.00
340
0.74%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 41.3T 27.1B 27.3B 27.3B
Cost of revenue 9.0T 6.5B 5.7B 6.6B
Gross profit 32.3T 20.6B 21.6B 20.7B
Operating expense
Research & development 8.5T 5.7B 5.0B 4.6B
Selling general and admin 8.7T 6.1B 5.7B 5.2B
Other operating expenses
Operating income 15.1T 8.8B 11.0B 10.9B
Non operating interest income
Income 403.6B
Expense 1.4T 944M 935M 1.0B
Other income expense -13.1T -1.0B -4.2B -1.6B
Pretax income 990.9B 6.9B 5.8B 8.3B
Tax provision 303.0B 1.2B 1.2B 2.1B
Net income 689.3B 5.6B 4.6B 6.2B
Basic EPS 0.4 4.5 3.7 5.0
Diluted EPS 0.4 4.5 3.6 4.9
Basic average shares 1.8T 1.2M 1.2M 1.2M
Diluted average shares 1.8T 1.2M 1.2M 1.2M
EBITDA 19.5T 11.7B 12.5B 12.3B
Net income from continuing op. 689.3B 5.6B 4.6B 6.2B
Minority interests 0 52M 26M 24M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 10 hours 44 minutes

00:15
00:00
11:00
17:00
23:59

Trading Hours (Monday - Friday):

Main market
11:00 - 17:00
All times are displayed in the America/Argentina/Buenos_Aires timezone (-03, UTC-03:00).